Robust Bioconjugated Antigens Induce Immune Responses Preventing Malaria Infection and its Transmission
Small · 2026
DOI: 10.1002/smll.202508762 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von Nivethika Sivakumaran und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre For Cell Factories and Biopolymers, Institute For Biomedicine and Glycomics, Griffith University, Nathan, Australia. Hauptthemen laut MEDLINE: Malaria Vaccines, Malaria, Antigens, Protozoan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Foundation for the National Institutes of Health, Centre for Cell Factories and Biopolymers at Griffith University, Griffith Institute for Biomedicine and Glycomics at Griffith University.
Abstract (Originalsprache)
Malaria remains a major global health challenge, with current vaccines providing only limited reductions in case numbers. This study introduces an innovative approach that utilizes engineered Escherichia coli to bioconjugate and assemble the pre‐erythrocytic circumsporozoite protein‐derived RTS,S antigen and the sexual‐stage Pfs47 subdomain into biopolymer particles (BPs), generating the dual‐antigen Pfs47‐RTS,S‐BP vaccine. Compared to single‐antigen BPs, the fused Pfs47‐RTS,S‐BP formulation shows synergistic enhancement in immunogenicity and protective efficacy. Pfs47‑RTS,S‑BP retains its physical properties and antigenicity after storage at 37°C. Although functional in vivo assessment of these thermostable formulations has not yet been performed, the findings indicate promising thermostability that could help overcome cold‑chain limitations in malaria‑endemic regions. Pfs47‐RTS,S‐BP induces durable antibody and T cell responses alongside crucial liver‐resident memory T cells for frontline defence. Vaccine‐induced antibodies efficiently neutralize sporozoites and inhibit parasite transmission. Pfs47‐RTS,S‐BP generates RTS,S‐specific antibody levels 5.3‐fold higher than the protective thresholds of the current RTS,S/AS01 vaccine. The Pfs47‐RTS,S‐BP formulation also achieves 80.4% protection against mosquito bite challenge and 68.15% transmission‐reducing activity, demonstrating strong potential as a robust, dual‐stage malaria vaccine candidate. Overall, this work underscores the potential of Pfs47‑RTS, S‑BP to overcome key limitations of current vaccines and to substantially advance global malaria control efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre For Cell Factories and Biopolymers, Institute For Biomedicine and Glycomics, Griffith University, Nathan, Australia.
- W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
- Johns Hopkins Malaria Research Institute, Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
- Leiden University Center For Infectious Diseases (LUCID), Leiden University Medical Center, Leiden, The Netherlands.
- Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands.
ORCID-Profile: Bernd H A Rehm
Förderung
- Foundation for the National Institutes of Health
- Centre for Cell Factories and Biopolymers at Griffith University
- Griffith Institute for Biomedicine and Glycomics at Griffith University
- Australian Research Council
- NIAID NIH HHS
Zitieren
APA
Sivakumaran, N., Flores-Garcia, Y., Naar, C. M., Chen, S., Mehta, M., van Leeuwen, F. W. B., Tripathi, A., Murugan, R., Roestenberg, M., Zavala, F., & Rehm, B. H. A. (2026). Robust Bioconjugated Antigens Induce Immune Responses Preventing Malaria Infection and its Transmission. Small. https://doi.org/10.1002/smll.202508762
Vancouver
Sivakumaran N, Flores-Garcia Y, Naar CM, Chen S, Mehta M, van Leeuwen FWB, et al. Robust Bioconjugated Antigens Induce Immune Responses Preventing Malaria Infection and its Transmission. Small. 2026. doi:10.1002/smll.202508762
BibTeX
@article{Sivakumaran2026,
author = {Sivakumaran, Nivethika and Flores-Garcia, Yevel and Naar, Chanel M and Chen, Shuxiong and Mehta, Mili and van Leeuwen, Fijs W B and Tripathi, Abhai and Murugan, Rajagopal and Roestenberg, Meta and Zavala, Fidel and Rehm, Bernd H A},
title = {Robust Bioconjugated Antigens Induce Immune Responses Preventing Malaria Infection and its Transmission},
journal = {Small},
year = {2026},
doi = {10.1002/smll.202508762}
}
EUVIMED